Cargando…
The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study
BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615968/ https://www.ncbi.nlm.nih.gov/pubmed/28443575 http://dx.doi.org/10.4274/balkanmedj.2016.1617 |
_version_ | 1783266701346865152 |
---|---|
author | Kılıç, Salih Çelik, Ahmet Çakmak, Hüseyin Altuğ Afşin, Abdülmecit Tekkeşin, Ahmet İlker Açıksarı, Gönül Memetoğlu, Mehmet Erdem Özpamuk Karadeniz, Fatma Şahan, Ekrem Alıcı, Mehmet Hayri Dereli, Yüksel Sinan, Ümit Yaşar Zoghi, Mehdi |
author_facet | Kılıç, Salih Çelik, Ahmet Çakmak, Hüseyin Altuğ Afşin, Abdülmecit Tekkeşin, Ahmet İlker Açıksarı, Gönül Memetoğlu, Mehmet Erdem Özpamuk Karadeniz, Fatma Şahan, Ekrem Alıcı, Mehmet Hayri Dereli, Yüksel Sinan, Ümit Yaşar Zoghi, Mehdi |
author_sort | Kılıç, Salih |
collection | PubMed |
description | BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions in patients who participated in the WARFARIN-TR study (The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in the Turkish population) in Turkey. STUDY DESIGN: Cross-sectional study. METHODS: The WARFARIN-TR study includes 4987 patients using warfarin and involved regular international normalized ratio monitoring between January 1, 2014 and December 31, 2014. Patients attended follow-ups for 12 months. The sample size calculations were analysed according to the density of the regional population and according to Turkish Statistical Institute data. The time in therapeutic range was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of the effect of warfarin and food-drug interactions with simple questions developed based on a literature review. RESULTS: The Turkey-wide time in therapeutic range was reported as 49.5%±22.9 in the WARFARIN-TR study. There were statistically significant differences between regions in terms of time in therapeutic range (p<0.001). The highest rate was reported in the Marmara region (54.99%±20.91) and the lowest was in the South-eastern Anatolia region (41.95±24.15) (p<0.001). Bleeding events were most frequently seen in Eastern Anatolia (41.6%), with major bleeding in the Aegean region (5.11%) and South-eastern Anatolia (5.36%). There were statistically significant differences between the regions in terms of awareness (p<0.001). CONCLUSION: Statistically significant differences were observed in terms of the efficacy, safety and awareness of warfarin therapy according to different geographical regions in Turkey. |
format | Online Article Text |
id | pubmed-5615968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Galenos Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-56159682017-10-02 The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study Kılıç, Salih Çelik, Ahmet Çakmak, Hüseyin Altuğ Afşin, Abdülmecit Tekkeşin, Ahmet İlker Açıksarı, Gönül Memetoğlu, Mehmet Erdem Özpamuk Karadeniz, Fatma Şahan, Ekrem Alıcı, Mehmet Hayri Dereli, Yüksel Sinan, Ümit Yaşar Zoghi, Mehdi Balkan Med J Original Article BACKGROUND: The time in therapeutic range values may vary between different geographical regions of Turkey in patients vitamin K antagonist therapy. AIMS: To evaluate the time in therapeutic range percentages, efficacy, safety and awareness of warfarin according to the different geographical regions in patients who participated in the WARFARIN-TR study (The Awareness, Efficacy, Safety and Time in Therapeutic Range of Warfarin in the Turkish population) in Turkey. STUDY DESIGN: Cross-sectional study. METHODS: The WARFARIN-TR study includes 4987 patients using warfarin and involved regular international normalized ratio monitoring between January 1, 2014 and December 31, 2014. Patients attended follow-ups for 12 months. The sample size calculations were analysed according to the density of the regional population and according to Turkish Statistical Institute data. The time in therapeutic range was calculated according to F.R. Roosendaal’s algorithm. Awareness was evaluated based on the patients’ knowledge of the effect of warfarin and food-drug interactions with simple questions developed based on a literature review. RESULTS: The Turkey-wide time in therapeutic range was reported as 49.5%±22.9 in the WARFARIN-TR study. There were statistically significant differences between regions in terms of time in therapeutic range (p<0.001). The highest rate was reported in the Marmara region (54.99%±20.91) and the lowest was in the South-eastern Anatolia region (41.95±24.15) (p<0.001). Bleeding events were most frequently seen in Eastern Anatolia (41.6%), with major bleeding in the Aegean region (5.11%) and South-eastern Anatolia (5.36%). There were statistically significant differences between the regions in terms of awareness (p<0.001). CONCLUSION: Statistically significant differences were observed in terms of the efficacy, safety and awareness of warfarin therapy according to different geographical regions in Turkey. Galenos Publishing 2017-07 2017-08-04 /pmc/articles/PMC5615968/ /pubmed/28443575 http://dx.doi.org/10.4274/balkanmedj.2016.1617 Text en © Copyright 2017, Trakya University Faculty of Medicine http://creativecommons.org/licenses/by/2.5/ Balkan Medical Journal |
spellingShingle | Original Article Kılıç, Salih Çelik, Ahmet Çakmak, Hüseyin Altuğ Afşin, Abdülmecit Tekkeşin, Ahmet İlker Açıksarı, Gönül Memetoğlu, Mehmet Erdem Özpamuk Karadeniz, Fatma Şahan, Ekrem Alıcı, Mehmet Hayri Dereli, Yüksel Sinan, Ümit Yaşar Zoghi, Mehdi The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title | The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title_full | The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title_fullStr | The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title_full_unstemmed | The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title_short | The Time in Therapeutic Range and Bleeding Complications of Warfarin in Different Geographic Regions of Turkey: A Subgroup Analysis of WARFARIN-TR Study |
title_sort | time in therapeutic range and bleeding complications of warfarin in different geographic regions of turkey: a subgroup analysis of warfarin-tr study |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615968/ https://www.ncbi.nlm.nih.gov/pubmed/28443575 http://dx.doi.org/10.4274/balkanmedj.2016.1617 |
work_keys_str_mv | AT kılıcsalih thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT celikahmet thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT cakmakhuseyinaltug thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT afsinabdulmecit thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT tekkesinahmetilker thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT acıksarıgonul thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT memetoglumehmeterdem thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT ozpamukkaradenizfatma thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT sahanekrem thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT alıcımehmethayri thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT dereliyuksel thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT sinanumityasar thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT zoghimehdi thetimeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT kılıcsalih timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT celikahmet timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT cakmakhuseyinaltug timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT afsinabdulmecit timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT tekkesinahmetilker timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT acıksarıgonul timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT memetoglumehmeterdem timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT ozpamukkaradenizfatma timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT sahanekrem timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT alıcımehmethayri timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT dereliyuksel timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT sinanumityasar timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy AT zoghimehdi timeintherapeuticrangeandbleedingcomplicationsofwarfarinindifferentgeographicregionsofturkeyasubgroupanalysisofwarfarintrstudy |